8-K//Current report
Adaptimmune Therapeutics PLC 8-K
Accession 0001558370-25-010785
$ADAPCIK 0001621227operating
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:30 PM ET
Size
267.9 KB
Accession
0001558370-25-010785
Documents
- 8-Kadap-20250807x8k.htmPrimary
8-K
- EX-10.1adap-20250807xex10d1.htm
EX-10.1
- EX-10.2adap-20250807xex10d2.htm
EX-10.2
- GRAPHICadap-20250807xex10d2001.jpg
GRAPHIC
- GRAPHICadap-20250807xex10d2002.jpg
GRAPHIC
- GRAPHICadap-20250807xex10d2005.jpg
GRAPHIC
- GRAPHICadap-20250807xex10d2006.jpg
GRAPHIC
- EX-101.SCHadap-20250807.xsd
EX-101.SCH
- EX-101.LABadap-20250807_lab.xml
EX-101.LAB
- EX-101.PREadap-20250807_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001558370-25-010785-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLadap-20250807x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001621227
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 4:30 PM ET
- Size
- 267.9 KB